Clinical study of Fuzheng Huayu tablet combined with entecavir in the treatment of non-first-line NAs in blood stasis blocking the meridians syndrome of compensated chronic hepatitis B cirrhosis

Cai Ming, Wang Jingjing

PDF(1019 KB)
Modern Medicine Journal of China ›› 2025, Vol. 27 ›› Issue (4) : 14-20. DOI: 10.3969/j.issn.1672-9463.2025.04.003

Clinical study of Fuzheng Huayu tablet combined with entecavir in the treatment of non-first-line NAs in blood stasis blocking the meridians syndrome of compensated chronic hepatitis B cirrhosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(4): 14-20 https://doi.org/10.3969/j.issn.1672-9463.2025.04.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1019 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉